---
title: GLP-1 Users Are Spending More on Fitness and Less on Snacks and Restaurants
description: GLP-1 users pour money into fitness while cutting snacks, drink and restaurants, but the shift is concentrated among affluent users and may not last.
author: Darie Nani (Editor-in-Chief)
updated: 2026-08-28T17:19:01.289Z
canonical: https://www.sovereignmagazine.com/article/glp-1-consumer-spending-fitness-shift
image: https://cdn.nanimediahouse.com/glp1-consumer-spending-shift-219540.webp
categories: Economy
content_type: Analysis
region: United States
publication: Sovereign Magazine
schema_type: Article
---

A new consumer report says the people taking weight-loss drugs like Ozempic and Wegovy are rerouting real money into fitness, buying gym memberships, personal training, supplements and recovery while pulling back on eating out, snacking and alcohol. The Consumer Collective, a US consumer-insights and advisory firm, put numbers to a shift analysts have tracked for two years: as appetite falls and weight comes off, spending changes with it. For an operator, investor or brand strategist watching the consumer economy, the question is not whether the shift is real but whether it lasts, or whether it is a spike concentrated among a wealthy, already-health-conscious group that fades when the prescriptions stop.

## A big spending gap, from a small sample

The report, "How America Spends on Fitness," found that GLP-1 users say they spend $449 a month on fitness across categories, against $120 a month for people not taking the drugs. That figure is the one the report leads with, and it rests on a subsample of just 123 users drawn from an online survey of 500 US adults in July 2026, so it is best read as a directional finding rather than a precise market number.

The texture underneath it is more useful than the top line. The survey found 81% of GLP-1 users report paying for a gym membership, against 43% of non-users, and that users report spending more on personal training, supplements and recovery. They report walking more, doing more cardio and eating more protein, and eating out, snacking and drinking alcohol less than before they started. Weight loss shows up at the register too: the report says 63.4% of users bought new clothes because of weight changes, and more than two-thirds say they have dropped at least two sizes.

> "Fitness is one of the most important categories to consumers right now, but it's also an area where they tighten spending when things get tough. This report identifies shifting consumer habits and bright spots where spending is likely to remain fairly steady."
> — Allison Collins, cofounder, The Consumer Collective

Collins co-founded the firm with Jessica Ramirez; Collins spent fifteen years in journalism, nine of them at Women's Wear Daily, and Ramirez came from retail trend forecasting and investment advisory work. Their read is that some of this spending sticks and some of it does not, and separating the two is where the money is.

## Grocery bills fall even as baskets get healthier

The independent data corroborates the direction of the fitness shift while sharpening one point where the survey and the transaction data diverge. The report suggests GLP-1 users spend more at the grocery store; peer-reviewed transaction data shows the total bill falling. A Cornell University study published in the Journal of Marketing Research, drawing on a Numerator panel of 150,000 households, found grocery spending [fell about 5% to 6% within six months](https://www.news.cornell.edu/stories/2025/12/ozempic-changing-foods-americans-buy) of a household starting the drugs, with higher-income households down about 8%. The basket does change: it shifts toward protein and produce and away from snacks, candy and baked goods. The total grocery spend falls even as the food inside the cart gets healthier.

That combination, less volume but better quality, is what has food and beverage strategists rerunning their forecasts. FTI Consulting, tracking Circana and AlphaWise transaction data, [projects roughly $95 billion of packaged-food spending and $54 billion of foodservice spending at risk by 2030](https://www.fticonsulting.com/insights/articles/glp-1-drugs-rewriting-rules-food-beverage) as GLP-1 use spreads. In its read, frozen foods, snacks, alcohol and quick-service restaurants decline while fresh protein, produce, yogurt, supplements and full-service dining gain. The fitness spending in the survey is one visible edge of that same reallocation.

## The buyers skew wealthy and were already active

The durability question turns first on who these buyers are. A Morning Consult analysis of 58,000 GLP-1 users found they skew affluent and educated: 31% earn over $100,000, against 14% of all adults, and 27% hold a master's degree, against 12%. They were also disproportionately health-motivated before they ever filled a prescription. Heavier fitness spending, then, tracks with wealth and prior habits as much as with the drug. The survey's own generational cut points the same way, putting millennials highest at $345 a month on fitness and at a 29% usage rate.

The independent fitness and apparel numbers confirm the trend but run more modest than the survey's gap. A William Blair survey found gym membership among users rose to about 35% after starting, up from 24%, a real lift but well short of the 81% in the report. PwC found roughly a 10% lift in apparel spending, and the apparel effect is the most robustly confirmed of any of these, backed by PwC, Circana and Bernstein. The clothing purchases in the survey are the piece most likely to hold.

## The spending lasts as long as the drug does

The spending is tied to the medication, and the medication does not always last. Actuarial and clinical research puts GLP-1 discontinuation at roughly 36% to 65% within twelve months, with cost the most-cited reason. About two-thirds of lost weight is regained within a year of stopping. Numerator, tracking 30,000 consumers over time, found 52% of users cut spending about 10% across more than 100 categories within six months, and that after people stop the drug the changes revert within three to six months, with candy and baked goods rebounding fastest. On this evidence, the behavior lasts about as long as the appetite suppression does, and no longer.

Cost is easing but has not disappeared as a reason people quit. Out-of-pocket prices have fallen from around $1,000 to $1,350 a month to roughly $350, still two to four times what patients pay in Europe, and only about a third of US employers covered the drugs for weight loss as of 2024. Goldman Sachs has revised its market-size projections downward. The survey's prevalence figures, 15% currently taking a drug and 25% ever, sit at the high end of the range; Gallup's 2026 polling puts current use closer to 11% and ever-use around 15%.

A wealthy, health-primed cohort is spending more on fitness and better food while the drug is in their system, and the apparel and grocery-quality shifts have the strongest independent support. How much of that outlasts the prescription is still unsettled. It depends on how many people stay on the drugs as prices keep falling, and how much of the new habit holds once the appetite suppression ends.

## FAQ

**Q: What is a GLP-1 drug?**
It is a class of medicines, originally developed for type 2 diabetes, that curb appetite and slow digestion. Ozempic, Wegovy, Zepbound and Mounjaro are brand names in the category.